Modification of vasoconstrictor responses in cerebral blood vessels by lesioning of the trigeminal nerve: possible involvement of CGRP
- PMID: 8536296
- DOI: 10.1046/j.1468-2982.1995.1505373.x
Modification of vasoconstrictor responses in cerebral blood vessels by lesioning of the trigeminal nerve: possible involvement of CGRP
Abstract
The functional role of the trigeminal system has been addressed in experiments on the cortical surface of alpha-chloralose anaesthetized cats. Application of calcitonin gene-related peptide (CGRP) caused a concentration-dependent increase in arteriolar calibre by 38 +/- 5% (n = 8) with an IC50 of 2 nM. Cerebral veins did not relax upon CGRP administration (n = 12). Substance P (SP) was less potent but showed dilatation of both arterioles (21 +/- 4%) and veins (16 +/- 4%). The cerebrovascular trigeminal system was investigated after chronic (14 days) surgical lesion of the trigeminal nerve with the concomitant disappearance of perivascular CGRP/SP immunoreactive nerves. The cortical arteriolar responses to subarachnoid microinjections of acidic (pH 6.8) and basic CSF (pH 7.6) as well as noradrenaline (10(-4) M), neuropeptide Y (10(-7) M), prostaglandin F2x (10(-6 M), barium chloride (10(-4) M), and autologous blood (5 microl) were examined in anaesthetized cats with lesions of the trigeminal nerve, and were compared with their effects in sham-operated animals. The magnitude of the vasodilator and vasoconstrictor responses to these agents was unaffected by trigeminal lesions. However, duration of the vasoconstriction produced by basic CSF, but not the vasodilitation to acidic CSF, was markedly prolonged by trigeminal lesions (from 0.8 +/- 0.1 min to 2.2 +/- 0.3 min, p < 0.01). Also, the vasoconstrictor responses to noradrenaline, prostaglandin F2x, barium chloride, and autologous blood were significantly prolonged, while the maximum contractile effect to each agent was similar in lesioned as in sham-operated controls. The effects of CGRP, SP, and neurokinin A (NKA) have been examined on isolated cerebral arteries in vitro. Different CGRP analogues induced a strong relaxation with no difference in Imax (85-96%) or pD2 values (8.65 - 9.12). NKA induced a stronger relaxation than SP (Imax: 33% and 13%, respectively). SP was more potent than NKA (pD2:8.7 and 7.7, respectively). Capsaicin, a substance which selectively causes the release of stored sensory neuropeptides (CGRP, SP, NKA), caused in vitro relaxation of precontracted arteries. This relaxation was not affected by the neurokinin blocker spantide, but shifted towards higher capsaicin concentrations by the CGRP antagonist (CGRP 8-37. Thus, in this preparation CGRP rather than a neurokinin (SP/NKA) is responsible for the capsaicin-induced dilatations.
Comment in
-
What is the physiological role of the trigeminovascular system?Cephalalgia. 1995 Oct;15(5):333. Cephalalgia. 1995. PMID: 8536289 No abstract available.
Similar articles
-
Calcitonin gene-related peptide: functional role in cerebrovascular regulation.Proc Natl Acad Sci U S A. 1986 Aug;83(15):5731-5. doi: 10.1073/pnas.83.15.5731. Proc Natl Acad Sci U S A. 1986. PMID: 3488550 Free PMC article.
-
Effects of neuropeptide Y, calcitonin gene-related peptide, substance P, and capsaicin on cerebral arteries in man and animals.J Neurosurg. 1988 Dec;69(6):913-8. doi: 10.3171/jns.1988.69.6.0913. J Neurosurg. 1988. PMID: 2461438
-
The involvement of calcitonin gene-related peptide (CGRP) and substance P in feline pial artery diameter responses evoked by capsaicin.Neuropeptides. 1995 Sep;29(3):129-35. doi: 10.1016/0143-4179(95)90014-4. Neuropeptides. 1995. PMID: 8538873
-
Neuropeptides in migraine and cluster headache.Cephalalgia. 1994 Oct;14(5):320-7. doi: 10.1046/j.1468-2982.1994.1405320.x. Cephalalgia. 1994. PMID: 7828188 Review.
-
[Calcitonin gene-related peptide and neural control of vascular tone].Nihon Yakurigaku Zasshi. 1993 Jan;101(1):1-15. doi: 10.1254/fpj.101.1_1. Nihon Yakurigaku Zasshi. 1993. PMID: 8444377 Review. Japanese.
Cited by
-
Anti-migraine Calcitonin Gene-Related Peptide Receptor Antagonists Worsen Cerebral Ischemic Outcome in Mice.Ann Neurol. 2020 Oct;88(4):771-784. doi: 10.1002/ana.25831. Epub 2020 Aug 7. Ann Neurol. 2020. PMID: 32583883 Free PMC article.
-
Therapeutic antibodies against CGRP or its receptor.Br J Clin Pharmacol. 2015 Jun;79(6):886-95. doi: 10.1111/bcp.12591. Br J Clin Pharmacol. 2015. PMID: 25614243 Free PMC article. Review.
-
The CGRP receptor antagonist BIBN4096 inhibits prolonged meningeal afferent activation evoked by brief local K+ stimulation but not cortical spreading depression-induced afferent sensitization.Pain Rep. 2017 Dec 5;3(1):e632. doi: 10.1097/PR9.0000000000000632. eCollection 2018 Jan. Pain Rep. 2017. PMID: 29430561 Free PMC article.
-
CGRP and its receptors provide new insights into migraine pathophysiology.Nat Rev Neurol. 2010 Oct;6(10):573-82. doi: 10.1038/nrneurol.2010.127. Epub 2010 Sep 7. Nat Rev Neurol. 2010. PMID: 20820195 Review.
-
Treatment of migraine attacks based on the interaction with the trigemino-cerebrovascular system.J Headache Pain. 2008 Feb;9(1):5-12. doi: 10.1007/s10194-008-0011-4. Epub 2008 Jan 23. J Headache Pain. 2008. PMID: 18217201 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous